| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,925 |
23,056 |
$2.90M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,375 |
5,472 |
$1.63M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,748 |
10,355 |
$1.30M |
| J2357 |
Injection, omalizumab, 5 mg |
494 |
364 |
$484K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,101 |
2,651 |
$359K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,271 |
1,159 |
$142K |
| 80053 |
Comprehensive metabolic panel |
12,762 |
11,405 |
$136K |
| 96401 |
|
508 |
415 |
$136K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,559 |
1,433 |
$104K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,340 |
5,422 |
$81K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
311 |
287 |
$54K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
532 |
500 |
$34K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
71 |
63 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,828 |
11,383 |
$24K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
182 |
164 |
$23K |
| 64493 |
|
30 |
28 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,528 |
6,747 |
$11K |
| 84484 |
|
1,717 |
1,033 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,614 |
28,531 |
$10K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
67 |
66 |
$9K |
| 64490 |
|
15 |
13 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
52 |
48 |
$7K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
87 |
83 |
$7K |
| 64483 |
|
21 |
12 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,970 |
3,448 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
28 |
26 |
$6K |
| 0002A |
|
74 |
69 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
229 |
193 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
1,522 |
1,396 |
$3K |
| 83605 |
|
158 |
125 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
39 |
38 |
$2K |
| 87400 |
|
72 |
27 |
$2K |
| 0001A |
|
41 |
41 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
15 |
14 |
$2K |
| 59025 |
Fetal non-stress test |
12 |
12 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,022 |
8,072 |
$990.59 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,528 |
1,405 |
$853.36 |
| 83690 |
|
1,377 |
1,268 |
$512.70 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38 |
29 |
$464.31 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
280 |
265 |
$412.89 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
663 |
385 |
$371.20 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,760 |
1,595 |
$278.07 |
| 81001 |
|
1,283 |
1,122 |
$255.27 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
144 |
121 |
$224.20 |
| 84703 |
|
712 |
666 |
$216.87 |
| 81003 |
|
442 |
377 |
$180.97 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,162 |
1,084 |
$160.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,362 |
1,138 |
$149.93 |
| Q3014 |
Telehealth originating site facility fee |
19 |
18 |
$132.22 |
| 85027 |
|
253 |
221 |
$81.04 |
| 71046 |
Radiologic examination, chest; 2 views |
239 |
201 |
$61.24 |
| 81025 |
|
231 |
194 |
$47.98 |
| 82077 |
|
63 |
59 |
$26.65 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
47 |
42 |
$14.08 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
2,296 |
1,875 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
412 |
244 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
620 |
522 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
54 |
51 |
$0.00 |
| 0753T |
|
99 |
68 |
$0.00 |
| 80305 |
|
13 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
13 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
15 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
19,854 |
10,860 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,101 |
1,546 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
653 |
481 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
890 |
750 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
17 |
12 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
673 |
398 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
29 |
26 |
$0.00 |
| 83735 |
|
43 |
41 |
$0.00 |
| 88342 |
|
17 |
12 |
$0.00 |
| 64494 |
|
13 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
13 |
12 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
12 |
$0.00 |